Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID - Université de Lorraine Access content directly
Journal Articles Inflammatory Bowel Diseases Year : 2022

Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID

Catherine Reenaers
Arnaud de Roover
  • Function : Author
Laurent Kohnen
  • Function : Author
Marion Simon
  • Function : Author
Guillaume Pourcher
  • Function : Author
Caroline Trang-Poisson
  • Function : Author
Sylvie Rajca
  • Function : Author
Simon Msika
  • Function : Author
Stéphanie Viennot
  • Function : Author
Romain Alttwegg
  • Function : Author
Mélanie Serrero
  • Function : Author
Philippe Seksik
  • Function : Author
Laurence Picon
  • Function : Author
Céline Bourbao Tournois
  • Function : Author
Renaud Gontier
  • Function : Author
Cyrielle Gilletta
  • Function : Author
Carmen Stefanescu
  • Function : Author
David Laharie
  • Function : Author
Xavier Roblin
  • Function : Author
Stéphane Nahon
  • Function : Author
Guillaume Bouguen
  • Function : Author
Franck Carbonnel
Alain Attar
  • Function : Author
Edouard Louis
  • Function : Author
Benoît Coffin
  • Function : Author

Abstract

Abstract Background The prevalence of obesity and the number of bariatric surgeries in both the general population and in patients with inflammatory bowel disease (IBD) have increased significantly in recent years. Due to small sample sizes and the lack of adequate controls, no definite conclusions can be drawn from the available studies on the safety and efficacy of bariatric surgery (BS) in patients with IBD. Our aim was to assess safety, weight loss, and deficiencies in patients with IBD and obesity who underwent BS and compare findings to a control group. Methods Patients with IBD and a history of BS were retrospectively recruited to centers belonging to the Groupe d’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Patients were matched 1:2 for age, sex, body mass index (BMI), hospital of surgery, and type of BS with non-IBD patients who underwent BS. Complications, rehospitalizations, weight, and deficiencies after BS were collected in cases and controls. Results We included 88 procedures in 85 patients (64 Crohn’s disease, 20 ulcerative colitis, 1 unclassified IBD) with a mean BMI of 41.6 ± 5.9 kg/m2. Bariatric surgery included Roux-en-Y gastric bypass (n = 3), sleeve gastrectomy (n = 73), and gastric banding (n = 12). Eight (9%) complications were reported, including 4 (5%) requiring surgery. At a mean follow-up of 34 months, mean weight was 88.6 ± 22.4 kg. No difference was observed between cases and controls for postoperative complications (P = .31), proportion of weight loss (P = .27), or postoperative deficiencies (P = .99). Conclusions Bariatric surgery is a safe and effective procedure in patients with IBD and obesity; outcomes in this patient group were similar to those observed in a control population.
No file

Dates and versions

hal-04168206 , version 1 (21-07-2023)

Identifiers

Cite

Catherine Reenaers, Arnaud de Roover, Laurent Kohnen, Maria Nachury, Marion Simon, et al.. Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID. Inflammatory Bowel Diseases, 2022, 28 (8), pp.1198-1206. ⟨10.1093/ibd/izab249⟩. ⟨hal-04168206⟩
17 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More